Market by Animal Type, Distribution Channel, Route of Administration, Product, and Country | Forecast 2019-2028
Triton’s report has established that the North American veterinary medicines market is likely to register growth in revenue at a CAGR of 3.41% in the predicted years of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market are:
•       United States
•       Canada
In the United States, the market is mainly motivated by the easy availability of veterinary medicines, along with the rise in pet ownership. Similarly, the number of livestock animals is also growing, further advancing the demand for veterinary medicines across the country. Additionally, the surge in the occurrence of multiple medical conditions among animals, coupled with the growth in the animal healthcare expenditure, is augmenting the demand for veterinary medicines. Therefore, such factors are primarily driving the veterinary medicines market’s progression in the United States.
Likewise, the rise in awareness of the importance of immunization in livestock and companion animals has increased the demand for veterinary medicines in Canada. This further contributes to the growth of the studied market. Additionally, the Canadian Veterinary Medical Association (CVMA) promotes veterinary drugs to the people, advocates responsible treatments for animals, and offers professional development opportunities. Above all, Canada is recognized as the top-performing country for its veterinary services, meeting significant international standards by the World Organization for Animal Health. This further increases the demand for veterinary medicines for animal treatments, in turn, fueling the Canadian veterinary medicines market’s development.
Merck & Co is an international healthcare company delivering novel health solutions via its prescription medicines, vaccines, animal health, and biologic therapies products. Its business segments comprise pharmaceutical, animal health, healthcare services, and alliances. The company has a comprehensive product portfolio that also includes therapeutic and preventive agents to treat asthma, type 2 diabetes, chronic hepatitis, and more. Moreover, it also provides vaccines for measles, rubella, and varicella, among others. It has its headquarter in the United States, with operations spread across the world.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   NORTH AMERICA VETERINARY MEDICINES MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1.  THREAT OF NEW ENTRANTS
2.2.2.  THREAT OF SUBSTITUTE PRODUCTS
2.2.3.  BARGAINING POWER OF BUYERS
2.2.4.  BARGAINING POWER OF SUPPLIERS
2.2.5.  THREAT OF COMPETITIVE RIVALRY
2.3. INDUSTRY COMPONENTS
2.4. LEGAL POLICY AND REGULATORY FRAMEWORK
2.5. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1.  RISE IN LIVESTOCK PRODUCTION
2.8.2.  SURGE IN VARIOUS MEDICAL CONDITIONS IN ANIMALS
2.8.3.  INCREASING OWNERSHIP OF PETS
2.9. MARKET RESTRAINTS
2.9.1.  ADVERSE EFFECTS OF POST-VACCINATION
2.9.2.  LACK OF ADEQUATE NUMBER OF VETERINARIANS
2.10. MARKET OPPORTUNITIES
2.10.1. GROWING ANIMAL HEALTHCARE EXPENDITURE
2.10.2. INCREASING DEMAND FOR VETERINARY SPECIALIZATION
2.11. MARKET CHALLENGES
2.11.1. STRINGENT REGULATIONS
2.11.2. HIGH COST OF ANIMAL VACCINES
3.   NORTH AMERICA VETERINARY MEDICINES MARKET OUTLOOK - BY ANIMAL TYPE
3.1. COMPANION ANIMALS
3.2. LIVESTOCK ANIMALS
4.   NORTH AMERICA VETERINARY MEDICINES MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
4.1. RETAIL VETERINARY PHARMACIES
4.2. VETERINARY HOSPITAL PHARMACIES
5.   NORTH AMERICA VETERINARY MEDICINES MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
5.1. PARENTERAL ROUTE
5.2. ORAL ROUTE
5.3. TOPICAL ROUTE
6.   NORTH AMERICA VETERINARY MEDICINES MAREKT OUTLOOK - BY PRODUCT
6.1. DRUGS
6.1.1.  ANTI-INFECTIVE
6.1.2.  ANTI-INFLAMMATORY
6.1.3.  PARASITICIDE
6.2. VACCINES
6.2.1.  INACTIVATED VACCINES
6.2.2.  ATTENUATED VACCINES
6.2.3.  RECOMBINANT VACCINES
6.3. MEDICATED FEED ADDITIVES
6.3.1.  ANTIBIOTICS
6.3.2.  AMINO ACIDS
7.   GEOGRAPHICAL ANALYSIS - NORTH AMERICA
7.1. COUNTRY ANALYSIS
7.1.1.  UNITED STATES
7.1.2.  CANADA
8.   COMPANY PROFILES
8.1. EVONIK INDUSTRIES AG (RAG STIFTUNG)
8.2. INDIAN IMMUNOLOGICALS LIMITED
8.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
8.4. MERCK & CO
8.5. ZOETIS
8.6. BIOGENESIS BAGO SA
8.7. VETOQUINOL (SOPARFIN SCA)
8.8. ARCHER DANIELS MIDLAND
8.9. CEVA SANTE ANIMALE
8.10. VIRBAC SA
8.11.  DECHRA PHARMACEUTICALS PLC
8.12. NEOGEN CORPORATION
8.13. ELANCO
8.14. HESTER BIOSCIENCES LIMITED
8.15. KINDRED BIOSCIENCES
9.   RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1.  OBJECTIVES OF STUDY
9.1.2.  SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1.  PRIMARY DATA SOURCES
9.2.2.  SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1.  EVALUATION OF PROPOSED MARKET
9.3.2.  IDENTIFICATION OF DATA SOURCES
9.3.3.  ASSESSMENT OF MARKET DETERMINANTS
9.3.4.  DATA COLLECTION
9.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: NUMBER OF HOUSEHOLDS OWNING PETS IN THE UNITED STATES (IN MILLION)
TABLE 3: NORTH AMERICA VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 3: NORTH AMERICA VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
FIGURE 20: UNITED STATES VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 21: CANADA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)